nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—ADRB1—dilated cardiomyopathy	0.277	0.543	CbGaD
Labetalol—ADRB2—dilated cardiomyopathy	0.233	0.457	CbGaD
Labetalol—Lisdexamfetamine—Lisinopril—dilated cardiomyopathy	0.151	0.377	CrCrCtD
Labetalol—Quinapril—Lisinopril—dilated cardiomyopathy	0.128	0.319	CrCrCtD
Labetalol—Benazepril—Lisinopril—dilated cardiomyopathy	0.122	0.304	CrCrCtD
Labetalol—Acute retention of urine—Furosemide—dilated cardiomyopathy	0.00766	0.122	CcSEcCtD
Labetalol—Drug fever—Spironolactone—dilated cardiomyopathy	0.00443	0.0704	CcSEcCtD
Labetalol—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0024	0.0382	CcSEcCtD
Labetalol—ADRB3—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00182	0.093	CbGpPWpGaD
Labetalol—ADRB3—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00148	0.0753	CbGpPWpGaD
Labetalol—Drug eruption—Furosemide—dilated cardiomyopathy	0.00131	0.0208	CcSEcCtD
Labetalol—Lethargy—Spironolactone—dilated cardiomyopathy	0.00109	0.0174	CcSEcCtD
Labetalol—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00108	0.0171	CcSEcCtD
Labetalol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00106	0.054	CbGpPWpGaD
Labetalol—Indecainide—SCN5A—dilated cardiomyopathy	0.000988	0.197	CrCbGaD
Labetalol—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000966	0.0154	CcSEcCtD
Labetalol—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000915	0.0146	CcSEcCtD
Labetalol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.000877	0.0447	CbGpPWpGaD
Labetalol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000854	0.0136	CcSEcCtD
Labetalol—Throat sore—Lisinopril—dilated cardiomyopathy	0.000837	0.0133	CcSEcCtD
Labetalol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.000829	0.0132	CcSEcCtD
Labetalol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000827	0.0131	CcSEcCtD
Labetalol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000771	0.0123	CcSEcCtD
Labetalol—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000687	0.0109	CcSEcCtD
Labetalol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000663	0.0106	CcSEcCtD
Labetalol—Alopecia—Spironolactone—dilated cardiomyopathy	0.000656	0.0104	CcSEcCtD
Labetalol—ADRB3—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000645	0.0329	CbGpPWpGaD
Labetalol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000621	0.00988	CcSEcCtD
Labetalol—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000603	0.00959	CcSEcCtD
Labetalol—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000599	0.00953	CcSEcCtD
Labetalol—Lethargy—Furosemide—dilated cardiomyopathy	0.000596	0.00947	CcSEcCtD
Labetalol—Wheezing—Lisinopril—dilated cardiomyopathy	0.000586	0.00932	CcSEcCtD
Labetalol—Malaise—Spironolactone—dilated cardiomyopathy	0.000583	0.00927	CcSEcCtD
Labetalol—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000569	0.00906	CcSEcCtD
Labetalol—Urinary retention—Furosemide—dilated cardiomyopathy	0.000555	0.00883	CcSEcCtD
Labetalol—Discomfort—Spironolactone—dilated cardiomyopathy	0.000543	0.00864	CcSEcCtD
Labetalol—ADRB3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000542	0.0276	CbGpPWpGaD
Labetalol—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000533	0.00848	CcSEcCtD
Labetalol—Confusional state—Spironolactone—dilated cardiomyopathy	0.000532	0.00846	CcSEcCtD
Labetalol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000527	0.00839	CcSEcCtD
Labetalol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000526	0.00836	CcSEcCtD
Labetalol—ADRB3—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000523	0.0266	CbGpPWpGaD
Labetalol—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000506	0.00805	CcSEcCtD
Labetalol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000481	0.00765	CcSEcCtD
Labetalol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000469	0.00745	CcSEcCtD
Labetalol—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000452	0.0072	CcSEcCtD
Labetalol—Drowsiness—Furosemide—dilated cardiomyopathy	0.00045	0.00715	CcSEcCtD
Labetalol—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000449	0.00714	CcSEcCtD
Labetalol—ADRB3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000439	0.0224	CbGpPWpGaD
Labetalol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000434	0.00691	CcSEcCtD
Labetalol—Sweating—Furosemide—dilated cardiomyopathy	0.000431	0.00686	CcSEcCtD
Labetalol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00042	0.00668	CcSEcCtD
Labetalol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000419	0.00666	CcSEcCtD
Labetalol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000417	0.00663	CcSEcCtD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000408	0.0208	CbGpPWpGaD
Labetalol—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0004	0.00636	CcSEcCtD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000397	0.0203	CbGpPWpGaD
Labetalol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000394	0.00627	CcSEcCtD
Labetalol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000389	0.00619	CcSEcCtD
Labetalol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000388	0.00618	CcSEcCtD
Labetalol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000375	0.0191	CbGpPWpGaD
Labetalol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000373	0.00593	CcSEcCtD
Labetalol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000372	0.00592	CcSEcCtD
Labetalol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000369	0.00586	CcSEcCtD
Labetalol—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000369	0.00586	CcSEcCtD
Labetalol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000361	0.00574	CcSEcCtD
Labetalol—Propafenone—SCN5A—dilated cardiomyopathy	0.000356	0.0709	CrCbGaD
Labetalol—Dysuria—Lisinopril—dilated cardiomyopathy	0.000354	0.00563	CcSEcCtD
Labetalol—Erythema—Furosemide—dilated cardiomyopathy	0.000351	0.00559	CcSEcCtD
Labetalol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000349	0.00555	CcSEcCtD
Labetalol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000349	0.00554	CcSEcCtD
Labetalol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000338	0.00537	CcSEcCtD
Labetalol—Depression—Lisinopril—dilated cardiomyopathy	0.000336	0.00535	CcSEcCtD
Labetalol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000335	0.00533	CcSEcCtD
Labetalol—Rash—Spironolactone—dilated cardiomyopathy	0.000332	0.00529	CcSEcCtD
Labetalol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000332	0.00528	CcSEcCtD
Labetalol—Vision blurred—Furosemide—dilated cardiomyopathy	0.000331	0.00527	CcSEcCtD
Labetalol—Headache—Spironolactone—dilated cardiomyopathy	0.00033	0.00525	CcSEcCtD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000329	0.0168	CbGpPWpGaD
Labetalol—Jaundice—Lisinopril—dilated cardiomyopathy	0.000329	0.00523	CcSEcCtD
Labetalol—Sweating—Lisinopril—dilated cardiomyopathy	0.000324	0.00515	CcSEcCtD
Labetalol—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000318	0.00506	CcSEcCtD
Labetalol—Vertigo—Furosemide—dilated cardiomyopathy	0.000316	0.00502	CcSEcCtD
Labetalol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000315	0.00501	CcSEcCtD
Labetalol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000315	0.0161	CbGpPWpGaD
Labetalol—Nausea—Spironolactone—dilated cardiomyopathy	0.000313	0.00498	CcSEcCtD
Labetalol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00031	0.0158	CbGpPWpGaD
Labetalol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000308	0.00491	CcSEcCtD
Labetalol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000305	0.0156	CbGpPWpGaD
Labetalol—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000303	0.00482	CcSEcCtD
Labetalol—Hallucination—Lisinopril—dilated cardiomyopathy	0.000301	0.00479	CcSEcCtD
Labetalol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000298	0.00475	CcSEcCtD
Labetalol—Confusional state—Furosemide—dilated cardiomyopathy	0.000289	0.0046	CcSEcCtD
Labetalol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000287	0.00456	CcSEcCtD
Labetalol—Shock—Furosemide—dilated cardiomyopathy	0.000282	0.00449	CcSEcCtD
Labetalol—Flushing—Lisinopril—dilated cardiomyopathy	0.000281	0.00447	CcSEcCtD
Labetalol—Fenoterol—ADRB1—dilated cardiomyopathy	0.000279	0.0555	CrCbGaD
Labetalol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000277	0.00441	CcSEcCtD
Labetalol—Hypotension—Furosemide—dilated cardiomyopathy	0.000268	0.00426	CcSEcCtD
Labetalol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000268	0.00426	CcSEcCtD
Labetalol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000265	0.00422	CcSEcCtD
Labetalol—Erythema—Lisinopril—dilated cardiomyopathy	0.000264	0.00419	CcSEcCtD
Labetalol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000261	0.0133	CbGpPWpGaD
Labetalol—Arbutamine—ADRB1—dilated cardiomyopathy	0.000261	0.0519	CrCbGaD
Labetalol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000258	0.0041	CcSEcCtD
Labetalol—Somnolence—Furosemide—dilated cardiomyopathy	0.000255	0.00406	CcSEcCtD
Labetalol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000254	0.00403	CcSEcCtD
Labetalol—Formoterol—ADRB1—dilated cardiomyopathy	0.000253	0.0504	CrCbGaD
Labetalol—Arformoterol—ADRB1—dilated cardiomyopathy	0.000253	0.0504	CrCbGaD
Labetalol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000249	0.00395	CcSEcCtD
Labetalol—Fatigue—Furosemide—dilated cardiomyopathy	0.000247	0.00393	CcSEcCtD
Labetalol—Tremor—Lisinopril—dilated cardiomyopathy	0.000247	0.00393	CcSEcCtD
Labetalol—Pain—Furosemide—dilated cardiomyopathy	0.000245	0.0039	CcSEcCtD
Labetalol—Constipation—Furosemide—dilated cardiomyopathy	0.000245	0.0039	CcSEcCtD
Labetalol—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000245	0.00389	CcSEcCtD
Labetalol—Salmeterol—ADRB2—dilated cardiomyopathy	0.000244	0.0485	CrCbGaD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000242	0.0124	CbGpPWpGaD
Labetalol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000241	0.0123	CbGpPWpGaD
Labetalol—Angioedema—Lisinopril—dilated cardiomyopathy	0.000241	0.00383	CcSEcCtD
Labetalol—Dobutamine—ADRB1—dilated cardiomyopathy	0.00024	0.0478	CrCbGaD
Labetalol—Malaise—Lisinopril—dilated cardiomyopathy	0.000238	0.00378	CcSEcCtD
Labetalol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000237	0.0121	CbGpPWpGaD
Labetalol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000237	0.00377	CcSEcCtD
Labetalol—Syncope—Lisinopril—dilated cardiomyopathy	0.000236	0.00376	CcSEcCtD
Labetalol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000236	0.00376	CcSEcCtD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000236	0.012	CbGpPWpGaD
Labetalol—Quinapril—ACE—dilated cardiomyopathy	0.000235	0.0469	CrCbGaD
Labetalol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000235	0.00373	CcSEcCtD
Labetalol—Fenoterol—ADRB2—dilated cardiomyopathy	0.000234	0.0467	CrCbGaD
Labetalol—Ritodrine—ADRB2—dilated cardiomyopathy	0.000234	0.0467	CrCbGaD
Labetalol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000233	0.00371	CcSEcCtD
Labetalol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000232	0.00369	CcSEcCtD
Labetalol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000231	0.0118	CbGpPWpGaD
Labetalol—Urticaria—Furosemide—dilated cardiomyopathy	0.000228	0.00362	CcSEcCtD
Labetalol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000227	0.00361	CcSEcCtD
Labetalol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000227	0.00361	CcSEcCtD
Labetalol—ADRB3—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000224	0.0114	CbGpPWpGaD
Labetalol—Discomfort—Lisinopril—dilated cardiomyopathy	0.000222	0.00353	CcSEcCtD
Labetalol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000221	0.0113	CbGpPWpGaD
Labetalol—Arbutamine—ADRB2—dilated cardiomyopathy	0.000219	0.0437	CrCbGaD
Labetalol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000217	0.00345	CcSEcCtD
Labetalol—Oedema—Lisinopril—dilated cardiomyopathy	0.000215	0.00342	CcSEcCtD
Labetalol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000215	0.00342	CcSEcCtD
Labetalol—Arformoterol—ADRB2—dilated cardiomyopathy	0.000213	0.0424	CrCbGaD
Labetalol—Formoterol—ADRB2—dilated cardiomyopathy	0.000213	0.0424	CrCbGaD
Labetalol—Shock—Lisinopril—dilated cardiomyopathy	0.000212	0.00337	CcSEcCtD
Labetalol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000211	0.00336	CcSEcCtD
Labetalol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000208	0.00331	CcSEcCtD
Labetalol—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000208	0.0106	CbGpPWpGaD
Labetalol—Asthenia—Furosemide—dilated cardiomyopathy	0.000206	0.00327	CcSEcCtD
Labetalol—Benazepril—ACE—dilated cardiomyopathy	0.000205	0.0408	CrCbGaD
Labetalol—Pruritus—Furosemide—dilated cardiomyopathy	0.000203	0.00323	CcSEcCtD
Labetalol—Dobutamine—ADRB2—dilated cardiomyopathy	0.000202	0.0402	CrCbGaD
Labetalol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000201	0.0032	CcSEcCtD
Labetalol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000196	0.00312	CcSEcCtD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000195	0.00996	CbGpPWpGaD
Labetalol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000193	0.00307	CcSEcCtD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000193	0.00985	CbGpPWpGaD
Labetalol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000192	0.00305	CcSEcCtD
Labetalol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000191	0.00304	CcSEcCtD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000191	0.00975	CbGpPWpGaD
Labetalol—Dizziness—Furosemide—dilated cardiomyopathy	0.00019	0.00302	CcSEcCtD
Labetalol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000189	0.00301	CcSEcCtD
Labetalol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000186	0.00295	CcSEcCtD
Labetalol—Constipation—Lisinopril—dilated cardiomyopathy	0.000184	0.00293	CcSEcCtD
Labetalol—Pain—Lisinopril—dilated cardiomyopathy	0.000184	0.00293	CcSEcCtD
Labetalol—Vomiting—Furosemide—dilated cardiomyopathy	0.000182	0.0029	CcSEcCtD
Labetalol—ADRB3—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000181	0.00924	CbGpPWpGaD
Labetalol—Rash—Furosemide—dilated cardiomyopathy	0.000181	0.00288	CcSEcCtD
Labetalol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000181	0.00287	CcSEcCtD
Labetalol—Headache—Furosemide—dilated cardiomyopathy	0.00018	0.00286	CcSEcCtD
Labetalol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000177	0.00282	CcSEcCtD
Labetalol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000176	0.0028	CcSEcCtD
Labetalol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000172	0.00876	CbGpPWpGaD
Labetalol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000171	0.00272	CcSEcCtD
Labetalol—Nausea—Furosemide—dilated cardiomyopathy	0.00017	0.00271	CcSEcCtD
Labetalol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00017	0.00271	CcSEcCtD
Labetalol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00017	0.00271	CcSEcCtD
Labetalol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00016	0.00814	CbGpPWpGaD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000159	0.00813	CbGpPWpGaD
Labetalol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000159	0.00252	CcSEcCtD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000156	0.00798	CbGpPWpGaD
Labetalol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000154	0.00246	CcSEcCtD
Labetalol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000152	0.00242	CcSEcCtD
Labetalol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000147	0.00234	CcSEcCtD
Labetalol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000142	0.00226	CcSEcCtD
Labetalol—Propafenone—ADRB1—dilated cardiomyopathy	0.000141	0.0282	CrCbGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000138	0.00705	CbGpPWpGaD
Labetalol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000137	0.00218	CcSEcCtD
Labetalol—Isoprenaline—ADRB1—dilated cardiomyopathy	0.000136	0.0271	CrCbGaD
Labetalol—Rash—Lisinopril—dilated cardiomyopathy	0.000136	0.00216	CcSEcCtD
Labetalol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000136	0.00216	CcSEcCtD
Labetalol—Headache—Lisinopril—dilated cardiomyopathy	0.000135	0.00214	CcSEcCtD
Labetalol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.00013	0.00662	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000129	0.00655	CbGpPWpGaD
Labetalol—Nausea—Lisinopril—dilated cardiomyopathy	0.000128	0.00203	CcSEcCtD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000124	0.00635	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000118	0.00604	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000118	0.00604	CbGpPWpGaD
Labetalol—Isoprenaline—ADRB2—dilated cardiomyopathy	0.000114	0.0228	CrCbGaD
Labetalol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000112	0.00572	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00011	0.00561	CbGpPWpGaD
Labetalol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000108	0.00548	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000107	0.00544	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000106	0.00542	CbGpPWpGaD
Labetalol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000102	0.00521	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000101	0.00514	CbGpPWpGaD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.46e-05	0.00482	CbGpPWpGaD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	9.29e-05	0.00474	CbGpPWpGaD
Labetalol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.26e-05	0.00472	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.11e-05	0.00464	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.02e-05	0.0046	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.02e-05	0.0046	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	8.64e-05	0.00441	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.39e-05	0.00428	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.21e-05	0.00418	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.12e-05	0.00414	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.03e-05	0.00409	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.63e-05	0.00389	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.46e-05	0.0038	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.23e-05	0.00368	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	7.03e-05	0.00358	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.03e-05	0.00358	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	6.94e-05	0.00354	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	6.88e-05	0.00351	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	6.88e-05	0.00351	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.58e-05	0.00335	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.54e-05	0.00333	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.41e-05	0.00327	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.39e-05	0.00326	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.31e-05	0.00322	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.19e-05	0.00316	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.17e-05	0.00315	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	5.99e-05	0.00305	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.41e-05	0.00276	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.35e-05	0.00273	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.35e-05	0.00273	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.29e-05	0.0027	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.24e-05	0.00267	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.24e-05	0.00267	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.13e-05	0.00261	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.1e-05	0.0026	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.1e-05	0.0026	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.98e-05	0.00254	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—AGT—dilated cardiomyopathy	4.88e-05	0.00249	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.87e-05	0.00248	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.74e-05	0.00242	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.72e-05	0.0024	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.63e-05	0.00236	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.63e-05	0.00236	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.59e-05	0.00234	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.3e-05	0.00219	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.17e-05	0.00212	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.12e-05	0.0021	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.03e-05	0.00205	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.92e-05	0.002	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.91e-05	0.00199	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.8e-05	0.00194	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.72e-05	0.0019	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.72e-05	0.0019	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.56e-05	0.00181	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.38e-05	0.00172	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.08e-05	0.00157	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.03e-05	0.00154	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.03e-05	0.00154	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.96e-05	0.00151	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.96e-05	0.00151	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	2.9e-05	0.00148	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.89e-05	0.00147	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	2.83e-05	0.00144	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.81e-05	0.00143	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.76e-05	0.00141	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.75e-05	0.0014	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.75e-05	0.0014	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.75e-05	0.0014	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.73e-05	0.00139	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.73e-05	0.00139	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.69e-05	0.00137	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.69e-05	0.00137	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.66e-05	0.00136	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.62e-05	0.00134	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.55e-05	0.0013	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.54e-05	0.0013	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	2.54e-05	0.0013	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	2.5e-05	0.00128	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.5e-05	0.00127	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.46e-05	0.00126	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.42e-05	0.00123	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.39e-05	0.00122	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.33e-05	0.00119	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.28e-05	0.00116	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.21e-05	0.00113	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.16e-05	0.0011	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.11e-05	0.00108	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.1e-05	0.00107	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.07e-05	0.00105	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.99e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.83e-05	0.000932	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.79e-05	0.000912	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.74e-05	0.000886	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.71e-05	0.000874	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.71e-05	0.000874	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.68e-05	0.000855	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.64e-05	0.000835	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.62e-05	0.000827	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.62e-05	0.000827	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.6e-05	0.000816	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.59e-05	0.000809	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.59e-05	0.000809	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.56e-05	0.000793	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.55e-05	0.00079	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.52e-05	0.000776	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.51e-05	0.000769	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.49e-05	0.000758	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	1.48e-05	0.000754	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.48e-05	0.000753	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.45e-05	0.000741	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.43e-05	0.000729	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.25e-05	0.000636	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.22e-05	0.000622	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.19e-05	0.000608	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.18e-05	0.000604	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.03e-05	0.000526	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.03e-05	0.000524	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.02e-05	0.000519	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.01e-05	0.000515	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.95e-06	0.000507	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.19e-06	0.000469	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	8.99e-06	0.000458	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	8.78e-06	0.000448	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	8.59e-06	0.000438	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.08e-06	0.000361	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	7.04e-06	0.000359	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.92e-06	0.000353	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.09e-06	0.000311	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.96e-06	0.000304	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	5.87e-06	0.000299	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	5.71e-06	0.000291	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	5.15e-06	0.000262	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.18e-06	0.000213	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.09e-06	0.000208	CbGpPWpGaD
